Stay updated on ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial
Sign up to get notified when there's something new on the ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial page.

Latest updates to the ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial page
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check15 days agoChange DetectedDifference0.4%
- Check22 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed inclusion and exclusion criteria for study participants and the addition of a comprehensive list of cancer types involved in the study. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference23%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.4%
- Check37 days agoChange DetectedThe page has been updated to include information on Renal Cell Carcinoma and has been revised to version 2.14.3, while information on Ovarian Epithelial Cancer has been removed.SummaryDifference0.2%
- Check44 days agoChange DetectedDifference0.4%
Stay in the know with updates to ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial page.